Bessemer Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-185
Closed -$2K 2687
2024
Q3
$2K Buy
+185
New +$2K ﹤0.01% 2279